TipRanks
Go Ultimate55% OFF

Geo Group (GEO1) AI Stock Analysis

MX:GEO1

Geo Group

(BMV:GEO1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Contract-driven growthContract wins and facility activations are supporting substantial revenue growth and expanding the operating base. This provides greater visibility than purely transactional demand, while the multi-year nature of government contracts can support continued revenue and earnings development over coming quarters.
Negative Factors
Government funding dependenceGEO’s growth depends heavily on government appropriations, procurement decisions, and policy direction, particularly from ICE. Funding interruptions or changed priorities can delay activations, disrupt revenue ramps, and make otherwise awarded opportunities less predictable over the medium term.

Geo Group (GEO1) vs. SPDR S&P 500 ETF (SPY)

-40%-20%0%20%40%60%80%MX:GEO1+67.32%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 3.75B
Dividend Yield
―
Average Volume (3M)
19
Price to Earnings (P/E)
13.3
Beta (1Y)
-0.74
Revenue Growth
4.94%
EPS Growth
204.40%
Country
Mexico
Employees
18,000
Sector
Industrials
Sector Strength
63
Industry
Security & Protection Services

Geo Group Business Overview & Revenue Model

Company Description

The GEO Group, Inc. is dedicated to the operation, leasing, and ownership of secure correctional centers, administrative processing hubs, and community reentry facilities situated in the United States, Australia, and South Africa. The company's opera...

Geo Group Earnings Call Summary

Earnings Call Date:Aug 05, 2026(Q2-2026)|% Change Since:-5.54%|Next Earnings Date:Nov 04, 2026
Earnings Call SentimentPositive

The call presented strong operational and financial momentum: solid top-line growth (+15% revenue), outsized net income and EPS gains (63% and 71%), improved adjusted EBITDA (+20%), raised full-year guidance, meaningful new ICE contracts that add significant bed capacity and future revenue, and active share repurchases. Key risks and challenges cited include timing delays for several managed contracts (Florida facilities), a temporary lapse in skip-tracing revenue due to funding disruptions, modest near-term ISAP headcount growth despite favorable device/case mix, higher operating expenses from activations, and uncertainty around potential asset sales to ICE. On balance, positive execution and upgraded guidance substantially outweigh the operational and timing risks described on the call.

Positive Updates

Revenue Growth
Second quarter 2026 revenues of approximately $732.1M vs $636.2M in Q2 2025, representing a 15% year-over-year increase driven by 2025 contract wins and facility activations.

Negative Updates

Skip Tracing Contract Revenue Disruption
No revenues recognized from the new skip tracing contract during Q2 2026, attributed to the lapse in ICE appropriations during the government shutdown; ramp expected in H2 2026 but timing uncertain.

Company Guidance

GEO raised 2026 guidance and provided quarterly outlooks: full‑year GAAP net income of $168–175M ($1.27–1.32/sh) on revenues of $2.95–3.05B with adjusted EBITDA of $550–560M and an effective tax rate of ~30% (incl. known discretes); total unreimbursed CapEx of $135–145M for 2026 (expected to drop below $100M in 2027). Quarterly targets are Q3 GAAP net income $45–48M ($0.35–0.37/sh) on revenues $755–805M with adjusted EBITDA $140–145M, and Q4 GAAP net income $37–41M ($0.28–0.31/sh) on revenues $758–808M with adjusted EBITDA $137–142M. Balance sheet and capital return metrics at Q2: $55M cash, $1.54B total debt, ~ $1.5B net debt, net leverage <3x adjusted EBITDA, ~ $300M total available liquidity, repurchased ~1.6M shares for ~$37M in Q2 (10.1M shares/$177M repurchased since Aug‑2025), ~130M shares outstanding and ~$323M remaining under a $500M buyback authorization. Guidance excludes earnings from the new Bighorn and Rivers activations and from the rescheduled Graceville (1.88k beds) and Bay (985 beds) managed contracts (≈$100M combined) and assumes more moderate H2 labor cost savings.

Geo Group Risk Analysis

Geo Group disclosed 13 risk factors in its most recent earnings report. Geo Group reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Geo Group Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

MX:GEO1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ALLEALLE82Outperform$15.72B23.1032.68%1.16%10.33%8.70%
ADTADT78Outperform$7.20B12.8016.83%2.23%2.10%6.68%
CXWCXW69Neutral$3.05B25.118.96%―24.35%32.67%
BCOBCO64Neutral$4.23B23.5664.68%0.99%8.12%16.12%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
SPCBSPCB62Neutral$63.18M62.881.94%―7.23%-50.82%

* Industrials Sector Average

Performance Comparison

-25%0%25%50%75%MX:GEO1BCOCXWALLESPCBADTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:GEO1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:GEO1Geo Group Inc512.00206.0067.32%
BCOBrink's102.71-7.16-6.51%
CXWCoreCivic30.8812.0363.82%
ALLEAllegion PLC186.4424.1414.88%
SPCBSuperCom Ltd.10.06-0.31-2.99%
ADTAdt, Inc.9.861.3415.74%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.